Pfizer Inc. (BVMF:PFIZ34)

Market Cap	771.90B
Revenue (ttm)	349.70B
Net Income (ttm)	58.90B
Shares Out	n/a
EPS (ttm)	10.38
PE Ratio	13.10
Forward PE	8.96
Dividend	1.65 (4.85%)
Ex-Dividend Date	Jul 24, 2025

Volume	2,787
Average Volume	17,508
Open	34.49
Previous Close	34.15
Day's Range	33.95 - 34.55
52-Week Range	30.84 - 42.45
Beta	0.47
RSI	52.28
Earnings Date	Nov 4, 2025

About Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral pr...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1849
• Employees: 81,000
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: PFIZ34

Financial Performance

In 2024, Pfizer's revenue was $63.63 billion, an increase of 6.84% compared to the previous year's $59.55 billion. Earnings were $8.03 billion, an increase of 279.00%.

Financial numbers in USD